Rajeev M. Shah
Director, KalVista Pharmaceuticals, Inc.
Companies
- Freenome, Inc.Board member Jul 22, 2026 to now1
- Parabilis Medicines, Inc.Board member Jun 9, 2026 to now2
- Hemab Therapeutics Holdings, Inc.Board member Apr 30, 2026 to now3
- SpyGlass Pharma, Inc.Board member Feb 5, 2026 to now4
- Evommune, Inc.Board member Nov 5, 2025 to now5
- Sionna Therapeutics, Inc.Board member Feb 6, 2025 to now6
- Septerna, Inc.Board member Oct 24, 2024 to now7
- Bicara Therapeutics Inc.Board member Sep 12, 2024 to now8
- Artiva Biotherapeutics, Inc.Board member Jul 18, 2024 to now9
- Cidara TherapeuticsBoard member Apr 30, 2024 to now10
- LENZ Therapeutics, Inc.Board member Mar 25, 2024 to now11
- Mineralys Therapeutics, Inc.Board member Feb 9, 2023 to now12
- Silverback TherapeuticsBoard member Nov 10, 2022 to now13
- Acrivon Therapeutics, Inc.Board member Nov 9, 2022 to now14
- PepGen Inc.Board member May 5, 2022 to now15
- Nkarta Therapeutics (United States)Board member Apr 28, 2022 to now16
- Tyra Biosciences, Inc.Board member Sep 14, 2021 to now17
- Wave Life SciencesBoard member Aug 18, 2021 to now18
- Climb Bio, Inc.Board member Aug 9, 2021 to now19
- Acumen Pharmaceuticals, Inc.Board member Jun 30, 2021 to now20
- Janux Therapeutics, Inc.Board member Jun 10, 2021 to now21
- Werewolf Therapeutics, Inc.Board member Apr 29, 2021 to now22
- Vor Biopharma Inc.Board member Feb 4, 2021 to now23
- 89bio, Inc.Board member Nov 8, 2019 to now24
- Jade Biosciences, Inc.Board member Jun 29, 2021 to Jun 20, 202425
- Icosavax, Inc.Board member Jul 28, 2021 to Feb 20, 202426
- Solid Biosciences Inc.Board member Jan 25, 2018 to Jan 12, 202427
- Black Diamond Therapeutics, Inc.Board member Jan 29, 2020 to Jul 7, 202328
- Satsuma Pharmaceuticals, Inc.Board member Sep 12, 2019 to Jun 8, 202329
- DICE Therapeutics, Inc.Board member Sep 14, 2021 to Mar 30, 202330
- iTeos Therapeutics, Inc.Board member Jun 10, 2022 to Jun 10, 202231
- Forma Therapeutics Holdings, Inc.Board member Jun 9, 2022 to Jun 9, 202232
- Cytek Biosciences, Inc.Board member Jul 22, 2021 to Mar 16, 202233
- POINT Biopharma Global Inc.Board member Jun 24, 2021 to Jun 30, 202134
- Kala Pharmaceuticals (United States)Board member Jul 19, 2017 to Jun 21, 202135
- Orchard TherapeuticsBoard member Feb 11, 2021 to Feb 11, 202136
- KalVista Pharmaceuticals, Inc.Board member Nov 23, 2016 to Oct 16, 201737
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Hemab Therapeutics Holdings, Inc. COAG6,314,525 shares38$199.2M at $31.55May 6, 2026
- Vor Biopharma Inc. VOR4,501,882 shares39$81.0M at $17.99Jul 16, 2026
- Cytek Biosciences, Inc. CTKB12,797,184 shares40$67.0M at $5.24Mar 11, 2022
- Mineralys Therapeutics, Inc. MLYS1,867,229 shares41$39.1M at $20.93Mar 31, 2026
- Septerna, Inc. SEPN725,443 shares42$26.6M at $36.66Aug 12, 2026
- Nkarta Therapeutics (United States) NKTX7,805,129 shares43$13.9M at $1.78Apr 26, 2022
- Freenome, Inc. FRNM750,000 shares44$9.2M at $12.32Jul 22, 2026
- Tyra Biosciences, Inc. TYRA442,721 shares45$8.5M at $19.27Feb 8, 2024
- Jade Biosciences, Inc. JBIO311,170 shares46$4.2M at $13.56Jun 20, 2024
Silverback Therapeutics SPRY902,904 shares47$3.9M at $4.29Nov 8, 2022- Kala Pharmaceuticals (United States) KALA8,045,299 shares48$1.6M at $0.20May 25, 2022
- Acumen Pharmaceuticals, Inc. ABOS588,850 shares49$1.0M at $1.75Mar 18, 2026
- Werewolf Therapeutics, Inc. HOWL443,825 shares50$459.4K at $1.03Jan 10, 2023
- Artiva Biotherapeutics, Inc. ARTV68,320 shares51$402.4K at $5.89Jul 14, 2026
- Forma Therapeutics Holdings, Inc.0 shares52Oct 14, 2022
- Satsuma Pharmaceuticals, Inc.0 shares53Jun 6, 2023
- 89bio, Inc.0 shares54Oct 30, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 12, 2026Sold 746,500 shares at $42.50 of Septerna, Inc.42
- Aug 12, 2026Sold 746,500 shares at $42.50 of Septerna, Inc.42
- Jul 16, 2026Sold 213 shares at $19.75 of Vor Biopharma Inc.39
- Jul 16, 2026Exercised 2,100,000 shares of Vor Biopharma Inc.39
- Jul 13, 2026Bought 6,552 shares at $8.94 of Artiva Biotherapeutics, Inc.51
- Jul 10, 2026Bought 15,102 shares at $8.97 of Artiva Biotherapeutics, Inc.51
- May 6, 2026Bought 53,407 shares at $24.83 of Hemab Therapeutics Holdings, Inc.38
- May 6, 2026Bought 14,611 shares at $23.77 of Hemab Therapeutics Holdings, Inc.38
- May 5, 2026Bought 10,268 shares at $25.00 of Hemab Therapeutics Holdings, Inc.38
- May 5, 2026Bought 87,143 shares at $24.59 of Hemab Therapeutics Holdings, Inc.38
- May 4, 2026Bought 133,750 shares at $18.00 of Hemab Therapeutics Holdings, Inc.38
- May 4, 2026Bought 2,541,250 shares at $18.00 of Hemab Therapeutics Holdings, Inc.38
- May 4, 2026Converted 221,188 shares of Hemab Therapeutics Holdings, Inc.38
- May 4, 2026Converted 1,009,052 shares of Hemab Therapeutics Holdings, Inc.38
- May 4, 2026Converted 3,607,846 shares of Hemab Therapeutics Holdings, Inc.38
- Apr 27, 2026Other 1,407,000 shares of Prelude Therapeutics Inc55
- Apr 27, 2026Other 250,000 shares of Adicet Bio, Inc.56
- Apr 22, 2026Sold 165,150 shares at $15.77 of Vor Biopharma Inc.57
- Apr 10, 2026Sold 828 shares at $15.75 of Vor Biopharma Inc.58
- Apr 9, 2026Sold 135,201 shares at $16.59 of Vor Biopharma Inc.58
- Apr 8, 2026Sold 130,862 shares at $16.91 of Vor Biopharma Inc.58
- Apr 8, 2026Sold 353,242 shares at $16.32 of Vor Biopharma Inc.58
- Mar 30, 2026Bought 58,300 shares at $24.16 of Mineralys Therapeutics, Inc.41
- Mar 27, 2026Bought 310,700 shares at $23.67 of Mineralys Therapeutics, Inc.41
- Mar 16, 2026Granted 6,060,606 shares at $3.30 of Acumen Pharmaceuticals, Inc.49
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARFreenome, Inc., Board member
- 2
- 3
- 4SEC EDGARSpyGlass Pharma, Inc., Board member
- 5SEC EDGAREvommune, Inc., Board member
- 6
- 7SEC EDGARSepterna, Inc., Board member
- 8
- 9
- 10SEC EDGARCidara Therapeutics, Board member
- 11
- 12
- 13
- 14
- 15SEC EDGARPepGen Inc., Board member
- 16
- 17SEC EDGARTyra Biosciences, Inc., Board member
- 18SEC EDGARWave Life Sciences, Board member
- 19SEC EDGARClimb Bio, Inc., Board member
- 20
- 21
- 22
- 23SEC EDGARVor Biopharma Inc., Board member
- 24SEC EDGAR89bio, Inc., Board member
- 25SEC EDGARJade Biosciences, Inc., Board member
- 26SEC EDGARIcosavax, Inc., Board member
- 27SEC EDGARSolid Biosciences Inc., Board member
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36SEC EDGAROrchard Therapeutics, Board member
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55SEC EDGARForm 4 filed Apr 28, 2026
- 56SEC EDGARForm 4 filed Apr 29, 2026
- 57SEC EDGARForm 4 filed Apr 24, 2026
- 58SEC EDGARForm 4 filed Apr 10, 2026